A report by The Lancet medical journal on a COVID-19 vaccine
developed and tested in Russia says it has shown promising results, but
adds that more work is needed.
In trials so far, the experimental Sputnik V vaccine has elicited an immune response and has brought no adverse side effects, according to Russian researchers. Doctors studied 76 healthy volunteers aged between 18 and 60, over six weeks.
In a peer review31867-5/fulltext) of the Russian studies, experts in The Lancet say the two studies31866-3/fulltext) by Denis Logunov and his team from the N F Gamaleya Research Institute of Epidemiology and Microbiology have several strengths.
Read more at:
Russia's COVID-19 vaccine: Trial results 'encouraging but small', say experts | Euronews
In trials so far, the experimental Sputnik V vaccine has elicited an immune response and has brought no adverse side effects, according to Russian researchers. Doctors studied 76 healthy volunteers aged between 18 and 60, over six weeks.
In a peer review31867-5/fulltext) of the Russian studies, experts in The Lancet say the two studies31866-3/fulltext) by Denis Logunov and his team from the N F Gamaleya Research Institute of Epidemiology and Microbiology have several strengths.
Read more at:
Russia's COVID-19 vaccine: Trial results 'encouraging but small', say experts | Euronews
No comments:
Post a Comment